2-(4-Chlorophenoxy)isobutyric Acid 2-(4-氯苯氧基)异丁酸
CAS 882-09-7 MFCD00004192
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- {SNA} APIs & Metabolites, APIs (Active Pharmaceutical Ingredients) & Metabolites, Additional Drugs, Additional Standards, Analytical Standards, Chromatography, Clofibrate Metabolites, Pharmaceutical Standards, Pharmaceuticals, Illicit Drugs & Alcohol, 分析/色谱
- {SA} Analytical Standards, Analytical/Chromatography, Building Blocks, C10, Carbonyl Compounds, Carboxylic Acids, Chemical Synthesis,
- Analytical Standards, Analytical/Chromatography, Building Blocks,
- {SNA} Building Blocks, C10, Carbonyl Compounds, Carboxylic Acids, Chemical Synthesis, Organic Building
产品应用
- A hypolipidemic compound
相关文献及参考
- [2]. Salgado R, et, al. Biodegradation of clofibric acid and identification of its metabolites. J Hazard Mater. 2012 Nov 30;241-242:182-9.
- [3]. Kawashima Y, et, al. Increased activity of stearoyl-CoA desaturation in liver from rat fed clofibric acid. Biochim Biophys Acta. 1982 Dec 13;713(3):622-8.
- FT-IR 2 (2), 2614:D / FT-IR 1 (2), 165:A / FT-NMR 1 (2), 1025:C / IR-Spectra (3), 945:E / NMR-Reference 2 (2), 160:B / RegBook 1 (2), 1761:H / Sax 6 , 798 / Sigma FT-IR 1 (2), 388:B / Structure Index 1 , 281:C:5
- Merck 14 ,2378
- [1]. Forman BM, et, al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl
- [1]. Forman BM, et, al. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4312-7.
安全信息
GHS Symbol
- H302 Harmful if swallowed 吞食有害
- P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
- P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
- P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
- P301+P312+P330
- P302+P352+P332+P313+P362+P364
- P305+P351+P338+P337+P313
- P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
- P501 Dispose of contents/container to..… 处理内容物/容器.....
- S36 Wear suitable protective clothing 穿戴适当的防护服;
- R22 Harmful if swallowed 吞咽有害
TYPE OF TEST : TDLo - Lowest published toxic dose ROUTE OF EXPOSURE : Unreported SPECIES OBSERVED : Human DOSE/DURATION : 260 mg/kg/91D TOXIC EFFECTS : Liver - other changes REFERENCE : ATHSBL Atherosclerosis (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.11- 1970- Volume(issue)/page/year: 36,159,1980
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 727 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : TSPMA6 Travaux de la Societe de Pharmacie de Montpellier. (Soc. de Pharmacie de Montpellier, Faculte de Pharmacie de Montpellier, Ave. Ch.-Flahault, 34060 Montpellier, France) V.1- 1942- Volume(issue)/page/year: 34,121,1974
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 683 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 3
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 683 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : RPTOAN Russian Pharmacology and Toxicology (English Translation). Translation of FATOAO. (Euromed Pub., 33, Woodlands Rd., Surbiton, Surrey, UK) V.30- 1967- Volume(issue)/page/year: 33,150,1970
TYPE OF TEST
TYPE OF TEST : Unscheduled DNA synthesis ROUTE OF EXPOSURE : Oral TEST SYSTEM : Rodent - rat DOSE/DURATION : 2100 mg/kg/1W (Continuous) REFERENCE : CRNGDP Carcinogenesis (London). (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1980- Volume(issue)/page/year: 12,1557,1991
其他信息
- MOL 文件:882-09-7.mol
- Alfa Aesar:2-(4-氯苯氧基)异丁酸,98% 2-(4-Chlorophenoxy)isobutyric acid, 98%(882-09-7)
- TCI Shanghai:2-(4-氯苯氧基)异丁酸 2-(4-Chlorophenoxy)isobutyric Acid,>;97.0%(T)(882-09-7)
- Clofibric acid 是PPARα激动剂,是一种降血脂剂。
- Acros Organics:2-(4-氯苯氧基)-2-甲基丙酸 2-(4-Chlorophenoxy)-2-methylpropionic acid, 99%(882-09-7)
- Sigma Aldrich:882-09-7(sigmaaldrich)
- 下游产品:氯贝特
- Hazard Note:Irritant
- 图谱信息:4-氯苯氧异丁酸(882-09-7)红外图谱(IR2) 4-氯苯氧异丁酸(882-09-7)质谱(MS) 4-氯苯氧异丁酸(882-09-7)红外图谱(IR1)
- 用途一:用于医药安妥明中间体
- 4-氯苯氧异丁酸价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2014/06/02 C0940 2-(4-氯苯氧基)异丁酸 2-(4-Chlorophenoxy)isobutyric Acid 500G 1980元 2014/06/02 C0940 2-(4-氯苯氧基)异丁酸 2-(4-Chlorophenoxy)isobutyric Acid 25G 273元 2010/06/21 189092500 4-氯苯氧异丁酸 2-(4-Chlorophenoxy)-2-methylpropionic acid 99% 250 GR 1346元
- 方法一:由对氯苯酚经缩合而得。将对氯苯酚和丙酮加入反应锅,搅拌下加入氢氧化钠,在20℃左右滴加氯仿,反应温度控制在25-30℃,此时反应激烈,当反应缓和后加热回流3h。蒸馏回收丙酮,加水,加热至70℃使溶解,加入盐酸至pH为2-3,冷却析出结晶。冷至10℃以下,甩滤,用水洗涤至无油状物,干燥,得成品。收率约为80%。
- 用途二:制药中间体,用于安妥明、安妥明铝盐、安妥明丙二酸酯等。